Literature DB >> 10374851

Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes.

R Hast1, M Eriksson, S Widell, I Arvidsson, P Bemell.   

Abstract

In order to study if dysplastic cells are part of the abnormal chromosomal clone in myelodysplastic syndromes (MDS) we used fluorescence in situ hybridization in combination with standard May-Grünwald-Giemsa morphology (MGG/FISH) to investigate the penetration of chromosomal abnormalities into dysplastic neutrophil granulocytes in five MDS patients with documented monosomy 7 or trisomy 8 in the bone marrow at diagnosis. Neutrophil dysplasia was defined as neutrophil granulocytes with extreme hypogranulation or with nuclear abnormalities of the pelgeroid type. In one patient all dysplastic cells were derived from the abnormal chromosomal clone, while in the other four cases only 6-43% of the hypogranulated neutrophils and 33-40% of the pelgeroid granulocytes exhibited the chromosomal marker. The results suggest that neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in MDS. It is not clear, however, if the disomic dysplastic cells were derived from a parallel MDS clone with a normal karyotype, or represent residual non-clonal, normal hematopoietic cells.

Entities:  

Mesh:

Year:  1999        PMID: 10374851     DOI: 10.1016/s0145-2126(99)00042-9

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  5 in total

1.  Serial morphologic observation of bone marrow in aplastic anemia in children.

Authors:  Fumio Bessho; Shinsaku Imashuku; Shigeyoshi Hibi; Masahiro Tsuchida; Tatsutoshi Nakahata; Sumio Miyazaki; Seiji Kojima; Ichiro Tsukimoto; Nobuyuki Hamajima
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

2.  Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

Authors:  Daniel T Starczynowski; Florian Kuchenbauer; Bob Argiropoulos; Sandy Sung; Ryan Morin; Andrew Muranyi; Martin Hirst; Donna Hogge; Marco Marra; Richard A Wells; Rena Buckstein; Wan Lam; R Keith Humphries; Aly Karsan
Journal:  Nat Med       Date:  2009-11-08       Impact factor: 53.440

Review 3.  Implication of microRNAs in the pathogenesis of MDS.

Authors:  Jing Fang; Melinda Varney; Daniel T Starczynowski
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows.

Authors:  Xiao Li; Lingyun Wu; Shaoxu Ying; Chunkang Chang; Quan Pu
Journal:  Int J Hematol       Date:  2008-02-07       Impact factor: 2.490

5.  Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study.

Authors:  Tatiana Raskovalova; Marc G Berger; Marie-Christine Jacob; Sophie Park; Lydia Campos; Carmen Mariana Aanei; Julie Kasprzak; Bruno Pereira; José Labarère; Jean-Yves Cesbron; Richard Veyrat-Masson
Journal:  Haematologica       Date:  2019-04-19       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.